
Mateusz Opyrchal
Program Leader - Phase · Indiana University School of Medicine
Credentials: · · · · · · · ·
History
- 2010–2012
Medical Oncology

- 2003–2007
Research
Annals of Surgical Oncology · 2019 · 148 citations
The Journal of Immunology · 2014 · 123 citations
Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Review · Current Cancer Drug Targets · 2018 · 112 citations

14 papers

12 papers

7 papers

6 papers
- CM
6 papers

6 papers

6 papers
- AE
5 papers
Grants
- 1999–2029
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $217.1K · Indiana University Indianapolis
- 2023–2028
Targeting FOXP3 mRNA Splicing for Breast Cancer Immunotherapy
National Cancer Institute · R01
PI · $2.3M · Indiana University Indianapolis
- 2022–2026
Targeting Immunoproteasome-Mediated Antigen Presentation in Colorectal Cancer Immunotherapy
National Cancer Institute · R01
PI · $1.5M · Indiana University Indianapolis
Clinical trials
- 2024
Organoid Model Predictive of Response to Immunotherapies
Principal investigator · Terminated
Indiana University
- 2020–2021
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
- 2019
Study of Oral PQR309 in Patients With Advanced Solid Tumors
Study director · Completed · Phase 1
PIQUR Therapeutics AG


